March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Race matters when it comes to HIV – and not just for women of color. Learn not only about the differences in HIV rates by race, but also understand the root of why these differences exist.
Get tips on talking to the media as well as the best ways to use social media in advocacy around HIV/AIDS.
Surviving HIV Over the Long Term: The Past, Present, and the Future (Part 2 of 2) is the 5th webinar in the 2016 WATCH! series.